• In February 2026, Herbalife Ltd. reported fourth-quarter 2025 sales of US$1,283.0 million and net income of US$85.4 million, issued 2026 net sales growth guidance, and announced plans to refinance up to US$1.55 billion of senior secured debt to extend its maturity profile.
• At the same time, Herbalife highlighted its push into personalized nutrition and digital health through its Pro2col platform, supported by a US$7.5 million investment and services commitment from Cristiano Ronaldo for a 10% stake in its Pro2col subsidiary.
• We’ll now examine how Herbalife’s planned US$1.55 billion debt refinancing may influence this existing investment narrative and risk-reward balance.

Invest in the nuclear renaissance through our list of 84 elite nuclear energy infrastructure plays powering the global AI revolution.

Herbalife Investment Narrative Recap

To own Herbalife today, you need to believe its shift toward personalized, tech-enabled wellness can offset pressure on its traditional MLM supplement model and support stable cash generation. In the near term, the key catalyst is execution on digital platforms like Pro2col and maintaining distributor engagement, while the biggest risk is Herbalife’s leveraged balance sheet and limited interest cover. The proposed US$1.55 billion refinancing directly targets this risk, but terms, pricing and successful completion remain uncertain.

The most relevant recent announcement here is Herbalife’s new 2026 net sales guidance, which calls for 1% to 6% year-over-year growth. That outlook, set just days before the refinancing news, frames how investors may weigh any change in interest costs or flexibility against management’s expectations for modest top-line improvement, particularly as the company leans on Pro2col and digital health tools to support future sales.

Yet despite this progress, investors should be aware that Herbalife’s high leverage and interest coverage constraints could...

Herbalife’s narrative projects $5.6 billion revenue and $152.6 million earnings by 2028. This requires 4.4% yearly revenue growth and a $172.4 million earnings decrease from $325.0 million today.

Uncover how Herbalife's forecasts yield a $14.00 fair value, a 29% downside to its current price.

Exploring Other Perspectives

While consensus once assumed steady progress, the lowest analysts were projecting revenue of about US$5.7 billion and earnings near US$175.8 million, highlighting a much more pessimistic view that could shift again after this refinancing news.

Explore 8 other fair value estimates on Herbalife - why the stock might be worth as much as 59% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Herbalife research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Herbalife research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Herbalife's overall financial health at a glance.

Interested In Other Possibilities?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Find 51 companies with promising cash flow potential yet trading below their fair value.
• Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Uncover the next big thing with 31 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.